Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer

Seminars in Oncology

Volumn 23, Issue 6 SUPPL. 14, 1996, Pages 8-14

  Kelly, W K ^a   Slovin, S ^a   Scher, H I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANDROGEN; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; ESTRAMUSTINE; ETOPOSIDE; HYDROCORTISONE; PROSTATE SPECIFIC ANTIGEN; RETINOIC ACID; SURAMIN; TRIMETREXATE;

BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SCREENING; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TREATMENT OUTCOME;

HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0030444947     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)